Managing Side Effects of Cancer Patients Treated With Immunotherapy
Presented by Brianna Hoffner,(1) MSN, RN, ANP-BC, AOCNP®, and Laura J. Zitella,(2) MS, RN, ACNP-BC, AOCN®
1)University of Colorado, Aurora, Colorado; 2)Stanford Cancer Institute, Stanford, California
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2018;9(3):287–292 |
© 2018 Harborside™
Immunotherapy has proven activity in several types of cancer; however, the mechanisms of action of immunotherapy can cause several different immune-related toxicities. Advanced practitioners are in a unique position to recognize the timing and manage these toxicities to help patients realize the maximal clinical efficacy of their therapy.
For access to the full length article, please sign in